[ad_1]
JAKARTA: Indonesia said on Friday (November 13) that it had requested emergency authorization to start a mass vaccination campaign by the end of the year, as the country’s COVID-19 infections reached a new daily record.
In an interview with Reuters, President Joko Widodo, commonly known as Jokowi, said that plans had already been advanced to distribute the vaccine across the country.
If approval is granted by the country’s food and drug agency, known by its Indonesian acronym BPOM, it will mean that Indonesia, with 270 million people, the fourth most populous country in the world, will be among the first in the world to implement a coronavirus vaccine.
“We hope to begin the vaccination process later this year after a series of tests conducted by BPOM,” Jokowi said.
READ: Indonesia Signs Billion Dollar Loan Agreement with Australia for COVID-19 Relief
Indonesia has struggled to suppress the coronavirus for months. On Friday, Indonesia recorded 5,444 new COVID-19 infections, its largest daily increase in cases.
The latest figures bring Indonesia’s total COVID-19 count to 457,735. The country has the highest number of coronavirus cases in Southeast Asia, although health experts caution that those numbers are likely higher due to low testing rates.
A further 104 deaths were also reported on Friday, bringing the total deaths to 15,037, the highest in Southeast Asia.
“We will push the cases to stay flat and then we will attack him with vaccines,” Jokowi told Reuters at the presidential palace.
Jokowi added that ensuring vaccine safety was a priority and that health workers, the police and the military would be first in line when the vaccination campaign begins.
At a ministerial round table after Jokowi’s interview, the coordinating minister for Maritime Affairs and Investments, Luhut Pandjaitan, said that the government expects the approval of the BPOM in the first week of December and that Indonesia will “start vaccinating” two weeks later. .
The vaccines produced by Sinovac and Sinopharm of China are expected to be used in the early stages of the campaign. This year, the companies will provide 18 million vaccines, including 15 million that will be manufactured by Indonesia’s state pharmaceutical company Bio Farma.
In total, Indonesia has agreements for more than 250 million doses until the end of 2021. This includes 30 million produced by the US company Novavax, the coordinating minister of the Economy, Airlangga Hartarto told Reuters.
READ: Shot in the Dark: COVID-19 Vaccine Early Efficacy Explained
ECONOMIC BOOST
Over the past two quarters, Indonesia’s economy has contracted at a slower rate than other countries in the region, and Jokowi said the economic trend was “encouraging.”
“Hopefully this (vaccination campaign) will have a positive economic impact. This is very important to us.”
He said the passage of a huge job creation bill that simplified 79 existing laws to boost investment, stimulate business activity and boost employment was a “major structural reform” that would add more impetus to the economy.
The implementation of the reform package, known as the Omnibus law, will be completed by the end of the year, Jokowi said.
When the bill was passed, there were widespread protests from workers, students and environmentalists, and several unions have challenged the law in the Constitutional Court.
Such activism is normal in a democracy, the president said, adding that he was not concerned about requests for judicial review against the new law.
The protests have petered out in recent weeks and Jokowi said the government has reached out to unions and large Islamic organizations to convince them of the benefits of the Omnibus laws.
“The Indonesian government is firmly committed to carrying out structural reforms and accelerating economic transformation … through the enactment of the job creation law,” he said.
CHECK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments
Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram